News Article | December 9, 2016
The International Association of HealthCare Professionals is pleased to welcome Philippe Chu, MD, Radiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Chu is a highly trained and qualified radiologist with a vast expertise in all facets of his work, especially radiology and body imaging. Dr. Chu has been in practice for more than 10 years and is currently serving patients at Franklin Hospital, Department of Radiology in Manhasset, New York and is also affiliated with North Shore LIJ. Dr. Chu graduated with his Medical Degree in 2004 from SUNY Downstate Medical Center. Following his graduation, he then interned at Staten Island University Hospital, served his residency at Nassau University Medical Center, and underwent fellowship training in Body Imaging at North Shore University Hospital. Dr. Chu maintains professional memberships with the American Roentgen Ray Society, the Radiological Society of North America, the American College of Radiology, and the American Institute of Ultrasound in Medicine. Dr. Chu is certified by the American Board of Radiology, and stays up to date with the latest advances and developments in his field by attending 2-3 conferences per year. He attributes his success to his good experience in residency training, and his great mentors along the way. Learn more about Dr. Chu here: https://www.northwell.edu/find-care/find-a-doctor/diagnostic-radiology/dr-philippe-chu-md-11352653 and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit:http://www.findatopdoc.com
News Article | December 5, 2016
Sabah Shah MD, MBA has joined the Retina Group of New York (RGONY) specializing in uveitis and vitreoretinal surgery. The Retina Group of New York was founded by James M. Maisel, MD and has been providing tertiary medical and surgical retinal care on Long Island for over 30 years. Dr. Shah has always followed a legacy of surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. Shah emulated the role of a physician as a medical healer. At the age of 17, she was only one of 18 high school students in the entire country accepted directly into medical school from high school. She was granted direct admission into the 8-year Leadership in Medicine program at Union University and Albany Medical College. She excelled academically during her studies, attaining a dual Bachelor’s degree in Biology and Spanish, an MBA in healthcare administration, and lastly her medical degree from Albany Medical College. After graduating at the top of her class from Albany Medical College, Dr. Shah completed her internship at New York Presbyterian-Queens of Weill Cornell Medical Center. She then completed a prestigious three-year ophthalmology residency at New York University and Manhattan Eye, Ear & Throat Hospital, training under world-renowned retina specialists. Upon completing her residency training, Dr. Shah returned to upstate New York to complete a two-year combined fellowship in vitreoretinal surgery and uveitis. Dr. Shah was appointed as Assistant Professor of Ophthalmology at Albany Medical College and was awarded the Resident Teaching Award for her excellence in instructing surgical and medical techniques to residents. During her training, Dr. Shah has published numerous papers on anti-VEGF medications including Avastin, Lucentis and Eylea, and procedures that are currently used by retina specialists such as retinal detachment repair and macular pucker surgery. She has participated in ongoing clinical trials involving pathology for macular degeneration and uveitis. Furthermore, Dr. Shah has presented her research, received research scholarships and awards, and has given lectures at the national level to hundreds of physicians across the country. Dr. Maisel states, “It is a privilege to have Dr. Shah join RGONY as the only ophthalmologist on Long Island to be fellowship trained in both retina and uveitis. Dr. Shah has extensive experience in some of the most sophisticated and groundbreaking medical and surgical techniques and we look forward to having her bring that expertise to RGONY and our patients. She has performed thousands of eye injections, retina lasers, and surgery for retinal detachment, macular puckers, and vitrectomies. Her comprehensive training, coupled with her amiable personality makes her a valuable addition to our specialized tertiary retina and uveitis practice.” Dr. Shah adds, “It is an honor to be a part of the medical and surgical community specializing in the management of retina and uveitis patients in Long Island. Having grown up in Long Island, I am excited to come back to serve my community. I enjoy meeting new patients and my passion in life is my career which enables me to restore vision and independence.” About the Retina Group of New York The Retina Group of New York has provided tertiary retinal and uveitis care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting edge diagnostic imaging, and integrated electronic records. The group holds staff privileges at seven area hospitals and teaching appointments at the Hofstra North Shore-LIJ School of Medicine, North Shore University Hospital, and Nassau University Medical Center. The practice is limited to medical and surgical retinal and uveitis problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macula pucker, macula hole, cataract surgery complications, uveitis, retinal degenerations, Plaquenil toxicity and second opinions. The group, led by CEO and founder James M. Maisel, MD, consists of Board Certified Ophthalmologists who have additional Fellowship Training from top institutions including New York Presbyterian-Cornell Medical Center, University of Pittsburgh and Albany Medical Center. They are complemented by specialized ophthalmic certified RNs, Health Information Management Specialists and Ophthalmic Technicians.The Retina Group of New York utilizes state-of-the-art diagnostic equipment and offers in-office laser treatment for diabetic retinopathy and treatment for macular degeneration and diabetic macular edema with intravitreal medications including Eylea®, Lucentis®, Ozurdex® and Iluvien®. Keeping abreast of the latest treatments, members of the group serve on the medical advisory boards of Regeneron, Allergan, Genetech and Alimera, and lecture across the U.S. to other retina specialists about macular degeneration and diabetic retinopathy. More information is available online at http://www.rgony.com.
News Article | November 23, 2016
The International Association of HealthCare Professionals is delighted to welcome Dr. James A. Gohar, MD, OBGYN, to their distinguished organization with a publication, coming soon in The Leading Physicians of the World. Dr. Gohar is a highly trained OBGYN, who currently practices at Forest Hills Medical Services PC, in Forest Hills, New York. He is affiliated with Mount Sinai-Roosevelt Hospital. Dr. Gohar has 10 years of experience in the areas of Obstetrics and Gynecology. Dr. Gohar graduated from Cairo University, in Gyza, Egypt, in 2003. Since then, he has completed internships at Nassau University Medical Center, in East Meadow, New York and his residency at Georgia Regents University. He is a member of American Congress of Obstetricians and Gynecologists, American Medical Association, and the Georgia Obstetrical and Gynecological Society. Dr. Gohar is fluent in Spanish in Arabic, as well. Dr. James A. Gohar attributes his success to his endless passion for his patient’s wellness and his values of good treatment. To learn more about Dr. Gohar, visit the site: james-gohar.findatopdoc.me and read his upcoming publication in the Leading Physicians of the World.
News Article | February 15, 2017
Total Orthopedics and Sports Medicine (http://www.totalorthosportsmed.com) announced today that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January 11, 2017 at Long Island Jewish, Valley Stream Medical Center in Valley Stream, NY. The procedure was an anterior cervical discectomy and fusion on a 42 year old female who was in a motor vehicle accident 7 months ago and suffered from left extremity radiculopathy. The patient had neurological deficits in her left arm and periodic right arm radiculopathy symptoms. MRI revealed a large foraminal disc herniation at the operative levels C4-5 and C5-6, loss of disc height, and significant kyphosis. Prior to undergoing surgery, the patient failed conservative treatment options including epidural injections, physical therapy, and medical management. Dr. Leven remarked on the advantages of Solofuse-P’s design in the operation: “Today’s case demonstrates a minimally invasive surgical technique to fuse the cervical spine. The Solofuse-P standalone device is zero profile, it does not extend beyond the disc space which prevents disruption to adjacent anatomical structures. The implant has a larger graft window which maximizes graft volume for better incorporation.” SpineFrontier’s A-CIFT Solofuse-P is a Less Exposure Surgery (LES®) technology designed with outpatient surgery in mind for quick recovery. Dr. Leven’s focus is on less invasive surgery, cervical spine surgery and spinal deformity using the LES philosophy. He is an associate professor with the orthopedic surgery residency program at Nassau University Medical Center and has a strong interest in teaching residents and medical students. As a physical therapist for 10 years prior to pursuing his medical training, he worked extensively with patients suffering from chronic pain, scoliosis, neuromuscular disorders, traumatic injuries and disability. He completed his training with the goal of maximizing his ability to help patients before, during and after surgery with a comprehensive treatment approach. His compassion for patients comes from hours of working with patients to improve their quality of life and Dr. Leven makes every effort to offer the best surgical option with the least invasive approach. Dr. Leven completed his orthopedic surgery residency at the State University of New York at Downstate in Brooklyn, NY. He went on to complete his spine surgery fellowship at Mount Sinai Hospital in Manhattan and trained extensively in minimally invasive surgery. SpineFrontier Inc. (http://www.spinefrontier.com) is a growing medical technology company that designs, develops and markets both implants and instruments for spine surgery based on the Less Exposure Surgery (LES®) Philosophy. These technologies are designed to allow for outpatient surgery due to minimal disruption of normal tissues. SpineFrontier believes LESS is more: LESS time in treatment and recovery is more time in action for patients and surgeons. SpineFrontier is headquartered in Malden, MA. It was founded in 2006, and released its first products in 2008. SpineFrontier is a KICVentures portfolio company and the leader in LES technologies and instruments.
News Article | February 8, 2017
In January, four children from New York State died from the flu, with pediatric flu death considered a key marker of a harsh flu season. This has prompted warnings for parents to stay alert. Influenza activity keeps increasing in the United States in general, and the U.S. Centers for Disease Control and Prevention put states like New Jersey and Pennsylvania in the red zone for the condition. Other places with high flu activity — based on the percentage of outpatient medical visits due to flu-like symptoms — include Kansas, New York, Missouri, Oklahoma, and South Carolina. As of Jan. 21, the flu outbreak has affected 37 U.S. states versus the previous 29 states, and in this time period three pediatric deaths also occurred due to flu infection. Kids bear the brunt of a strong flu season, with 15 children dying from flu in this season so far. There were 148 pediatric deaths in the 2014 to 2015 season and 89 last year. In Nassau University Medical Center, the pediatric nursing department is catering 24/7 to Long Island children with flu symptoms such as fever, chills, nausea, and muscle pains. “The cases of flu are continuing to increase week by week,” Dr. Rachel Robbins said in a CBS report. “We are right in the middle of flu season.” Public health officials recommend that everyone over the age of 6 months should be vaccinated. The nasal spray shot, however, is not used this year due to its lack of effectiveness in children. Child deaths are used as a parameter for how severe a flu season is. In mild ones, there are no pediatric deaths recorded, prompting epidemiologists to call the current outbreak “significant” so far. The CDC noted that while flu activity has been prevalent this year with many areas across the nation reporting illnesses, this has been an average year. The season is expected to peak in February until springtime. The reported cases, though, tell only half the story since it remains unknown how many flu cases the vaccine actually prevented. The CDC asserts that having more people vaccinated will reduce the chances of infection, and sometimes translate to lighter symptoms even when the recipient gets sick. For most, the flu will feel a lot worse than a typical cold, coming on suddenly and often accompanied by chills and fever. The flu usually comes with respiratory symptoms, headaches, and fatigue, with the occasional diarrhea and vomiting in children. At a higher risk for complications are kids under age 5 as well as adults 65 years old and above. They are advised to visit the doctor once they experience a fever exceeding 100.4 degrees Fahrenheit, severe body aches, and excessive fatigue. But it’s not yet too late to get a shot as well as prevent the disease through frequent hand washing, advised Susan Coffin of Children’s Hospital of Philadelphia. "You shouldn't send your kids to school while sick," she said, adding that patients are most contagious for around a half-day before they suffer symptoms and at the start of their actual illness. Read the CDC's Big Three ways to prevent the flu. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.
News Article | February 15, 2017
The American Diabetes Association of Greater New York and the Retina Group of New York proudly announce the 2017 EXPO being held on March 11, 2017, in the North Wing of the Jacob Javits Convention Center from 10am to 4pm. The Retina Group of New York, a leading Long Island group of vitreoretinal physicians, will be a presenting sponsor. James M. Maisel, MD, Founder and CEO of the Retina Group of New York will be speaking on “Advances in Diabetic Retinopathy Prevention, Diagnosis and Treatment.” This free community event will feature complimentary health screenings, healthy cooking demonstrations from celebrity chefs, exercise tips from nutrition and fitness experts, access to healthcare providers, multilingual presentations regarding diabetes prevention, multicultural community areas, a living-with-type 1 diabetes area, and a diabetes-goes-digital area. “The Retina Group of New York is committed to raising awareness about the need for regular screening for all diabetic patients for diabetic retinopathy, and in the prevention, diagnosis and treatment of diabetic retinopathy. In addition to faster and more accurate diagnosis of diabetic retinopathy, we are not only able to prevent blindness in almost all patients with laser and vitreous microsurgery, we can often improve vision with newer FDA approved medications,” said Dr. Maisel. “We are proud to serve as a presenting sponsor of the American Diabetes Association EXPO and to help reduce the prevalence of this preventable disease.” More than 10,000 attendees are expected from the Greater New York region. The EXPO aims to attract families affected by diabetes as well as those interested in learning how to live healthier, active lifestyles and changing the future of diabetes. “Every 11 seconds someone is diagnosed with diabetes,” said James Sheridan, Regional Vice President at the American Diabetes Association. “The fact is, nearly 30 million adults and children in the United States have diabetes—nearly 10 percent of the population. That percentage is even higher in New York City, reaching 14% in the African American and Latino population. And shockingly, many do not even know that they have the disease. That is why screening is so important.” Free, early registration is available at http://www.diabetes.org/exponyc About the American Diabetes Association The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, the Association’s mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. About The Retina Group of New York The Retina Group of New York has provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting-edge diagnostic equipment, and integrated electronic records. The group holds staff privileges at eight area hospitals and teaching appointments at the Hofstra Northwell School of Medicine, North Shore University Hospital, and NuHealth Nassau University Medical Center. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macular pucker, macula hole, surgery complications, uveitis, Plaquenil toxicity and second opinions. For more information on The Retina Group of New York, visit http://www.rgony.com, or call 516-939-6100 or 631-273-1818 for appointments.
News Article | December 16, 2016
The International Association of HealthCare Professionals is pleased to welcome Dr. Hilamber Subba, MD, Academic Hospitalist to their prestigious organization with his publication in The Leading Physicians of the World. Dr. Subba is an Academic Hospitalist with 12 years of experience and an extensive expertise in all facets of his work, especially internal medicine. Dr. Subba is currently serving patients at the Maine Medical Center in Portland, Maine and is also affiliated with The Barbara Bush Children’s Hospital. Dr. Subba’s career in medicine began in 2004, when he graduated with his Medical Degree from Manipal College of Medical Sciences in Nepal. Upon relocating to the United States, Dr. Subba went on to complete his internship at Nassau University Medical Center. To keep up to date with the latest advances in his field, Dr. Subba maintains a professional membership with the American Medical Association, the American College of Physicians, and the American Society of Addiction Medicine. For his excellence, he was recognized with a Best Teaching Excellence Award Among Internists for 2015 and 2016. Dr. Subba attributes his great success to his passion for medicine, and when he is not assisting patients, enjoys hiking. Learn more about Dr. Subba by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit http://www.findatopdoc.com
Frieri M.,Nassau University Medical Center
Current Allergy and Asthma Reports | Year: 2012
In systemic lupus erythematosus (SLE) patients, the role of inflammatory mediators is relevant to the pathogenesis of accelerated atherosclerosis. CD40 ligand is increased on circulating lymphocytes, correlates with double-stranded DNA, and has an important role in predicting risk of cardiovascular disease. Vascular endothelial growth factor (VEGF) is a tightly regulated angiogenic cytokine in the kidney, and plasma levels have been associated with disease activity. It has been correlated with lupus nephritis, associated with higher mean carotid intima media thickness, and can be a novel cardiovascular risk factor in premature coronary atherosclerosis. VEGF has been demonstrated in cultured human aortic endothelial cells in the presence of simvastatin and in kidney biopsies in lupus nephritis. SLE patients have been shown to manifest disturbances in gene expression involved in lipid transport and atheroma promotion. This paper provides evidence of the immune system in accelerated atherosclerosis in SLE, the role of selected proinflammatory cytokines, and therapeutic approaches. © 2011 Springer Science+Business Media, LLC.
Madeo J.,Nassau University Medical Center |
Frieri M.,Nassau University Medical Center
Aging and Disease | Year: 2013
Alzheimer's disease (AD) is a growing health care epidemic. It is the most common cause of dementia and its incidence is rising. Age, which influences the oxidative and inflammatory states of the brain, is the most important risk factor. Currently there is no disease modifying treatments available for this irreversible, progressive debilitating disease. Immunotherapy represents an emerging, potentially disease modifying strategy aimed at reducing the pathological lesions of AD and facilitating cognitive improvement. Many clinical trials are currently underway. This literature review highlights current knowledge regarding the physiology of aging and how it relates to the pathogenesis of AD. In addition, immunotherapy is discussed in the context of its mechanism, current studies and future goals.
Frieri M.,Nassau University Medical Center
Current allergy and asthma reports | Year: 2014
Good's syndrome and common variable immune deficiency (CVID) are associated with chronic rhinosinusitis. Good's syndrome is characterized by hypogammaglobulinemia, B-cell depletion, variable defects in cellular immunity and thymoma. Immunodeficiency and recurrent infections can initially present after thymectomy. The pathogenesis can involve cytokines from bone marrow along with genetic defects. Intravenous gamma globulin (IVIG) restores defective signaling and can reestablish immune homeostasis. IVIG at regular intervals is the most effective way to improve the clinical symptoms and reduce patient mortality. Increased awareness of the clinical and immunological profile of this syndrome may increase its early recognition. CVID patients have hypogammaglobulinemia, respond to IVIG and have a dysregulated antimicrobial peptide response to pathogenic bacteria in the upper respiratory tract. This article reviewed selected literature on Good's syndrome, described an unusual case of Good's syndrome, CVID including SAD related to chronic rhinosinusitis.